Dignam named as new RTOG group statistician

Justine Varieur Cadet | | Health Imaging | Oncology Imaging
James J. Dignam, PhD, has been named the new group statistician for the Radiation Therapy Oncology Group (RTOG) and will lead the efforts of RTOG's Statistics and Data Management Center. 

Dignam is an associate professor of biostatistics in the department of health studies at the University of Chicago and is an investigator at the University of Chicago Cancer Research Center. He has cancer clinical trial research background, having been a statistician for both the National Surgical Adjuvant Breast and Bowel Project and the American College of Surgeons Oncology Group (ACoSOG), in addition to his current work with the University of Chicago.

RTOG is a National Cancer Institute (NCI)-funded national clinical trials group and is administered by the American College of Radiology (ACR).

Justine Varieur Cadet

Related Content

MRI-first approach could allow many to safely forego prostate biopsy
MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer
Breast cancer only visible via MRI is often less aggressive

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.